BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hitch K, Joseph G, Guiltinan J, Kianmahd J, Youngblom J, Blanco A. Lynch syndrome patients' views of and preferences for return of results following whole exome sequencing. J Genet Couns 2014;23:539-51. [PMID: 24449059 DOI: 10.1007/s10897-014-9687-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Amendola LM, Lautenbach D, Scollon S, Bernhardt B, Biswas S, East K, Everett J, Gilmore MJ, Himes P, Raymond VM, Wynn J, Hart R, Jarvik GP; CSER Genetic Counseling Working Group. Illustrative case studies in the return of exome and genome sequencing results. Per Med 2015;12:283-95. [PMID: 26478737 DOI: 10.2217/pme.14.89] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
2 Kaphingst KA, Ivanovich J, Lyons S, Biesecker B, Dresser R, Elrick A, Matsen C, Goodman M. Preferences for learning different types of genome sequencing results among young breast cancer patients: Role of psychological and clinical factors. Transl Behav Med 2018;8:71-9. [PMID: 29385583 DOI: 10.1093/tbm/ibx042] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
3 Bartley N, Best M, Jacobs C, Juraskova I, Newson AJ, Savard J, Meiser B, Ballinger ML, Thomas DM, Biesecker B, Butow P. Cancer patients' views and understanding of genome sequencing: a qualitative study. J Med Genet 2020;57:671-6. [PMID: 31980566 DOI: 10.1136/jmedgenet-2019-106410] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
4 Cléophat JE, Dorval M, El Haffaf Z, Chiquette J, Collins S, Malo B, Fradet V, Joly Y, Nabi H. Whether, when, how, and how much? General public's and cancer patients' views about the disclosure of genomic secondary findings. BMC Med Genomics 2021;14:167. [PMID: 34174888 DOI: 10.1186/s12920-021-01016-8] [Reference Citation Analysis]
5 Berrios C, James CA, Raraigh K, Bollinger J, Murray B, Tichnell C, Applegate CD, Bergner AL. Enrolling Genomics Research Participants through a Clinical Setting: the Impact of Existing Clinical Relationships on Informed Consent and Expectations for Return of Research Results. J Genet Couns 2018;27:263-73. [PMID: 28932961 DOI: 10.1007/s10897-017-0143-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
6 Ormond KE, Rashkin M, Faucett WA. Standardizing Variant Interpretation in Genomic Sequencing: Implications for Genetic Counseling Practice. Curr Genet Med Rep 2015;3:137-42. [DOI: 10.1007/s40142-015-0073-y] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Bartley N, Napier C, Best M, Butow P. Patient experience of uncertainty in cancer genomics: a systematic review. Genet Med 2020;22:1450-60. [PMID: 32424175 DOI: 10.1038/s41436-020-0829-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
8 Esteban I, Lopez-Fernandez A, Balmaña J. A narrative overview of the patients' outcomes after multigene cancer panel testing, and a thorough evaluation of its implications for genetic counselling. Eur J Med Genet 2019;62:342-9. [PMID: 30476626 DOI: 10.1016/j.ejmg.2018.11.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Seo J, Ivanovich J, Goodman MS, Biesecker BB, Kaphingst KA. Information Topics of Greatest Interest for Return of Genome Sequencing Results among Women Diagnosed with Breast Cancer at a Young Age. J Genet Couns 2017;26:511-21. [PMID: 27542972 DOI: 10.1007/s10897-016-0006-2] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Costa S, Regier DA, Raymakers AJN, Pollard S. Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient Values. Patient 2021;14:187-96. [PMID: 32875479 DOI: 10.1007/s40271-020-00448-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Wouters RH, Bijlsma RM, Ausems MG, van Delden JJ, Voest EE, Bredenoord AL. Am I My Family's Keeper? Disclosure Dilemmas in Next-Generation Sequencing. Hum Mutat 2016;37:1257-62. [PMID: 27647774 DOI: 10.1002/humu.23118] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
12 Yu JH, Appelbaum PS, Brothers KB, Joffe S, Kauffman TL, Koenig BA, Prince AE, Scollon S, Wolf SM, Bernhardt BA, Wilfond BS; Clinical Sequencing Exploratory Research (CSER) Consortium Informed Consent and Governance Working Group. Consent for clinical genome sequencing: considerations from the Clinical Sequencing Exploratory Research Consortium. Per Med 2019;16:325-33. [PMID: 31313633 DOI: 10.2217/pme-2018-0076] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
13 Godino L, Varesco L, Bruno W, Bruzzone C, Battistuzzi L, Franiuk M, Miccoli S, Bertonazzi B, Graziano C, Seri M, Turchetti D. Preferences of Italian patients for return of secondary findings from clinical genome/exome sequencing. J Genet Couns 2021;30:665-75. [PMID: 33142017 DOI: 10.1002/jgc4.1350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Lewis KL, Facio FM, Berrios CD. Using the diffusion of innovations model to guide participant engagement in the genomics era. J Genet Couns 2019;28:419-27. [PMID: 30653790 DOI: 10.1002/jgc4.1090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Bijlsma RM, Bredenoord AL, Gadellaa-Hooijdonk CG, Lolkema MP, Sleijfer S, Voest EE, Ausems MG, Steeghs N. Unsolicited findings of next-generation sequencing for tumor analysis within a Dutch consortium: clinical daily practice reconsidered. Eur J Hum Genet 2016;24:1496-500. [PMID: 27071717 DOI: 10.1038/ejhg.2016.27] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
16 Albrechtsen RD, Goodman MS, Bather JR, Kaphingst KA. Impact of numeracy preferences on information needs for genome sequencing results. Patient Educ Couns 2021;104:467-72. [PMID: 33036816 DOI: 10.1016/j.pec.2020.09.032] [Reference Citation Analysis]
17 Kaphingst KA, Ivanovich J, Biesecker BB, Dresser R, Seo J, Dressler LG, Goodfellow PJ, Goodman MS. Preferences for return of incidental findings from genome sequencing among women diagnosed with breast cancer at a young age. Clin Genet 2016;89:378-84. [PMID: 25871653 DOI: 10.1111/cge.12597] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 4.9] [Reference Citation Analysis]
18 Krabbenborg L, Vissers LE, Schieving J, Kleefstra T, Kamsteeg EJ, Veltman JA, Willemsen MA, Van der Burg S. Understanding the Psychosocial Effects of WES Test Results on Parents of Children with Rare Diseases. J Genet Couns 2016;25:1207-14. [PMID: 27098417 DOI: 10.1007/s10897-016-9958-5] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 7.7] [Reference Citation Analysis]
19 Boardman F, Hale R. Responsibility, identity, and genomic sequencing: A comparison of published recommendations and patient perspectives on accepting or declining incidental findings. Mol Genet Genomic Med 2018;6:1079-96. [PMID: 30370638 DOI: 10.1002/mgg3.485] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
20 Scherr CL, Aufox S, Ross AA, Ramesh S, Wicklund CA, Smith M. What People Want to Know About Their Genes: A Critical Review of the Literature on Large-Scale Genome Sequencing Studies. Healthcare (Basel) 2018;6:E96. [PMID: 30096823 DOI: 10.3390/healthcare6030096] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
21 Kaphingst KA, Ivanovich J, Elrick A, Dresser R, Matsen C, Goodman MS. How, who, and when: preferences for delivery of genome sequencing results among women diagnosed with breast cancer at a young age. Mol Genet Genomic Med 2016;4:684-95. [PMID: 27896289 DOI: 10.1002/mgg3.254] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
22 Tafe LJ. Targeted Next-Generation Sequencing for Hereditary Cancer Syndromes. The Journal of Molecular Diagnostics 2015;17:472-82. [DOI: 10.1016/j.jmoldx.2015.06.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
23 Esteban I, Vilaró M, Adrover E, Angulo A, Carrasco E, Gadea N, Sánchez A, Ocaña T, Llort G, Jover R, Cubiella J, Servitja S, Herráiz M, Cid L, Martínez S, Oruezábal-Moreno MJ, Garau I, Khorrami S, Herreros-de-Tejada A, Morales R, Cano JM, Serrano R, López-Ceballos MH, González-Santiago S, Juan-Fita MJ, Alonso-Cerezo C, Casas A, Graña B, Teulé A, Alba E, Antón A, Guillén-Ponce C, Sánchez-Heras AB, Alés-Martínez JE, Brunet J, Balaguer F, Balmaña J. Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain. Psychooncology 2018;27:1530-7. [PMID: 29498768 DOI: 10.1002/pon.4686] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
24 Bartley N, Best M, Butow P. Pursuing germline genome sequencing to reduce illness uncertainty may involve additional uncertainties for cancer patients: A mixed-methods study. J Genet Couns 2021;30:1143-55. [PMID: 33786948 DOI: 10.1002/jgc4.1398] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Milner LC, Garrison NA, Cho MK, Altman RB, Hudgins L, Galli SJ, Lowe HJ, Schrijver I, Magnus DC. Genomics in the clinic: ethical and policy challenges in clinical next-generation sequencing programs at early adopter USA institutions. Per Med 2015;12:269-82. [PMID: 29771644 DOI: 10.2217/pme.14.88] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
26 Bijlsma RM, Wessels H, Wouters RHP, May AM, Ausems MGEM, Voest EE, Bredenoord AL. Cancer patients' intentions towards receiving unsolicited genetic information obtained using next-generation sequencing. Fam Cancer 2018;17:309-16. [PMID: 28852913 DOI: 10.1007/s10689-017-0033-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
27 Loud JT, Bremer RC, Mai PL, Peters JA, Giri N, Stewart DR, Greene MH, Alter BP, Savage SA. Research participant interest in primary, secondary, and incidental genomic findings. Genet Med 2016;18:1218-25. [PMID: 27101135 DOI: 10.1038/gim.2016.36] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
28 Meiser B, Butow P, Davies G, Napier CE, Schlub TE, Bartley N, Juraskova I, Ballinger ML, Thomas DM, Best MC; members of the Psychosocial Issues in Genomics in Oncology (PiGeOn) Project. Psychological predictors of cancer patients' and their relatives' attitudes towards the return of genomic sequencing results. Eur J Med Genet 2022;:104516. [PMID: 35487418 DOI: 10.1016/j.ejmg.2022.104516] [Reference Citation Analysis]
29 Shkedi-Rafid S, Dheensa S, Crawford G, Fenwick A, Lucassen A. Defining and managing incidental findings in genetic and genomic practice. J Med Genet 2014;51:715-23. [PMID: 25228303 DOI: 10.1136/jmedgenet-2014-102435] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
30 Amendola LM, Berg JS, Horowitz CR, Angelo F, Bensen JT, Biesecker BB, Biesecker LG, Cooper GM, East K, Filipski K, Fullerton SM, Gelb BD, Goddard KAB, Hailu B, Hart R, Hassmiller-Lich K, Joseph G, Kenny EE, Koenig BA, Knight S, Kwok PY, Lewis KL, McGuire AL, Norton ME, Ou J, Parsons DW, Powell BC, Risch N, Robinson M, Rini C, Scollon S, Slavotinek AM, Veenstra DL, Wasserstein MP, Wilfond BS, Hindorff LA, Plon SE, Jarvik GP; CSER consortium. The Clinical Sequencing Evidence-Generating Research Consortium: Integrating Genomic Sequencing in Diverse and Medically Underserved Populations. Am J Hum Genet 2018;103:319-27. [PMID: 30193136 DOI: 10.1016/j.ajhg.2018.08.007] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 17.7] [Reference Citation Analysis]
31 Saelaert M, Mertes H, Moerenhout T, Van Cauwenbergh C, Leroy BP, Devisch I, De Baere E. A qualitative study among patients with an inherited retinal disease on the meaning of genomic unsolicited findings. Sci Rep 2021;11:15834. [PMID: 34349199 DOI: 10.1038/s41598-021-95258-2] [Reference Citation Analysis]
32 Sayeed S, Califf R, Green R, Wong C, Mahaffey K, Gambhir SS, Mega J, Patrick-Lake B, Frazier K, Pignone M, Hernandez A, Shah SH, Fan AC, Krüg S, Shaack T, Shore S, Spielman S, Eckstrand J, Wong CA; Project Baseline Health Study Research Group. Return of individual research results: What do participants prefer and expect? PLoS One 2021;16:e0254153. [PMID: 34324495 DOI: 10.1371/journal.pone.0254153] [Reference Citation Analysis]
33 Mackley MP, Fletcher B, Parker M, Watkins H, Ormondroyd E. Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies. Genet Med 2017;19:283-93. [PMID: 27584911 DOI: 10.1038/gim.2016.109] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 12.3] [Reference Citation Analysis]
34 Janssens ACJW, Evans JP. Returning pharmacogenetic secondary findings from genome sequencing: let’s not put the cart before the horse. Genet Med 2015;17:854-6. [DOI: 10.1038/gim.2015.59] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
35 Bartley N, Napier CE, Butt Z, Schlub TE, Best MC, Biesecker BB, Ballinger ML, Butow P. Cancer Patient Experience of Uncertainty While Waiting for Genome Sequencing Results. Front Psychol 2021;12:647502. [PMID: 33967906 DOI: 10.3389/fpsyg.2021.647502] [Reference Citation Analysis]
36 Delanne J, Nambot S, Chassagne A, Putois O, Pelissier A, Peyron C, Gautier E, Thevenon J, Cretin E, Bruel AL, Goussot V, Ghiringhelli F, Boidot R, Tran Mau-Them F, Philippe C, Vitobello A, Demougeot L, Vernin C, Lapointe AS, Bardou M, Luu M, Binquet C, Lejeune C, Joly L, Juif C, Baurand A, Sawka C, Bertolone G, Duffourd Y, Sanlaville D, Pujol P, Geneviève D, Houdayer F, Thauvin-Robinet C, Faivre L. Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literature. Eur J Med Genet 2019;62:103529. [PMID: 30165243 DOI: 10.1016/j.ejmg.2018.08.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
37 Frost CJ, Andrulis IL, Buys SS, Hopper JL, John EM, Terry MB, Bradbury A, Chung WK, Colbath K, Quintana N, Gamarra E, Egleston B, Galpern N, Bealin L, Glendon G, Miller LP, Daly MB. Assessing patient readiness for personalized genomic medicine. J Community Genet 2019;10:109-20. [PMID: 29804257 DOI: 10.1007/s12687-018-0365-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
38 Soares BL, Brant AC, Gomes R, Pastor T, Schneider NB, Ribeiro-dos-santos Â, de Assumpção PP, Achatz MIW, Ashton-prolla P, Moreira MAM. Screening for germline mutations in mismatch repair genes in patients with Lynch syndrome by next generation sequencing. Familial Cancer 2018;17:387-94. [DOI: 10.1007/s10689-017-0043-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
39 Hong SJ. Uncertainty in the Process of Communicating Cancer-related Genetic Risk Information with Patients: A Scoping Review. J Health Commun 2020;25:251-70. [PMID: 32271688 DOI: 10.1080/10810730.2020.1745963] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Mackley MP, Blair E, Parker M, Taylor JC, Watkins H, Ormondroyd E. Views of rare disease participants in a UK whole-genome sequencing study towards secondary findings: a qualitative study. Eur J Hum Genet 2018;26:652-9. [PMID: 29440777 DOI: 10.1038/s41431-018-0106-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
41 Bredenoord AL, Bijlsma RM, van Delden H. Next Generation DNA Sequencing: Always Allow an Opt Out. Am J Bioeth 2015;15:28-30. [PMID: 26147261 DOI: 10.1080/15265161.2015.1039726] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
42 Bijlsma RM, Wouters RHP, Wessels H, May AM, Ausems MGEM, Voest EE, Bredenoord AL. Managing unsolicited findings in genomics: A qualitative interview study with cancer patients. Psychooncology 2018;27:1327-33. [PMID: 29471587 DOI: 10.1002/pon.4676] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
43 Rini C, Khan CM, Moore E, Roche MI, Evans JP, Berg JS, Powell BC, Corbie-Smith G, Foreman AKM, Griesemer I, Lee K, O'Daniel JM, Henderson GE. The who, what, and why of research participants' intentions to request a broad range of secondary findings in a diagnostic genomic sequencing study. Genet Med 2018;20:760-9. [PMID: 29261173 DOI: 10.1038/gim.2017.176] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
44 Hull LE, Vassy JL. Toward greater understanding of patient decision-making around genome sequencing. Per Med 2018;15:57-66. [PMID: 29714114 DOI: 10.2217/pme-2017-0037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
45 Martinez-Martin N, Magnus D. Privacy and ethical challenges in next-generation sequencing. Expert Rev Precis Med Drug Dev 2019;4:95-104. [PMID: 32775691 DOI: 10.1080/23808993.2019.1599685] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
46 Chavez-Yenter D, Vagher J, Clayton MF, Rindler M, Shukovich M, Kaphingst KA. "Being proactive, not reactive": exploring perceptions of genetic testing among White, Latinx, and Pacific Islander Populations. J Community Genet 2021;12:617-30. [PMID: 34415555 DOI: 10.1007/s12687-021-00542-3] [Reference Citation Analysis]
47 Krabbenborg L, Schieving J, Kleefstra T, Vissers LE, Willemsen MA, Veltman JA, van der Burg S. Evaluating a counselling strategy for diagnostic WES in paediatric neurology: an exploration of parents' information and communication needs. Clin Genet 2016;89:244-50. [PMID: 25916247 DOI: 10.1111/cge.12601] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]